Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

Pancreatic adenocarcinoma (PDAC) remains a formidable disease that needs improved therapeutic strategies. Even though immunotherapy has revolutionized treatment for various solid tumor types, it remains largely ineffective in treating individuals with PDAC. This review describes how the application...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Rev
Autors principals: Bowers, Jacob S., Bailey, Stefanie R., Rubinstein, Mark P., Paulos, Chrystal M., Camp, E. Ramsay
Format: Artigo
Idioma:Inglês
Publicat: PAGEPress Publications, Pavia, Italy 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686121/
https://ncbi.nlm.nih.gov/pubmed/31456872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2019.430
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars